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1Department of Anesthesiology, Columbia University College of Physicians and Surgeons, New York, New York, USA; and
2Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USAIntroduction: This prospective study tests the hypothesis that after general surgery urinary neutrophil
gelatinase–associated lipocalin (NGAL) can distinguish between sustained acute kidney injury (AKI),
typical of nephron damage, and transient AKI, commonly seen with hemodynamic variation and prerenal
azotemia.
Methods: Urine was collected in 510 patients within 2 to 3 hours after general surgery, and urinary NGAL
was determined using enzyme-linked immunosorbent assay. Patients who met AKIN stage 1 criteria of AKI
were subclassiﬁed into those with sustained AKI (serum creatinine elevation for at least 3 days) and those
with transient AKI (serum creatinine elevation for less than 3 days).
Results: Seventeen of 510 patients (3.3%) met the stage 1 AKIN criteria within 48 hours of surgery. Ele-
vations in serum creatinine were sustained in 9 and transient in 8 patients. Urinary NGAL was signiﬁcantly
elevated only in patients with sustained AKI (204.8  411.9 ng/dl); patients with transient AKI had urinary
NGAL that was indistinguishable from that of patients who did not meet AKIN criteria at all (30.8  36.5 ng/
dl vs. 31.9  113 ng/dl). The area under the curve of the receiver operating characteristic curve of urinary
NGAL to predict sustained AKI was 0.85 (95% conﬁdence interval: 0.773–0.929, P < 0.001).
Discussion: Urinary NGAL levels measured 2 to 3 hours after surgery were able to distinguish the kinetics
of creatinine (sustained AKI vs. transient AKI) over the subsequent week. Transient AKI is an easily
reversible state that is likely not associated with substantial tubular injury and therefore NGAL release.
Using AKIN criteria, both transient and sustained AKI are classiﬁed as AKI even though our data
demonstrate that they are possibly different entities.
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CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A cute kidney injury (AKI) is a diagnosis that isbased on the degree of increase in serum creati-
nine (SCr), the severity and duration of oliguria, or
both of these.1 However, SCr is not a proximate bio-
marker of kidney tubular injury, but rather an inte-
grator of multiple intrarenal and extrarenal functions,
and its ﬁnal concentration reﬂects the balance be-
tween creatinine production and excretion. Nonethe-
less, the Acute Kidney Injury Network (AKIN) and
Kidney Disease: Improving Global Outcomes (KDIGO)
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International Reports (2016) 1, 3–9potentially reversible decreases in glomerular ﬁltra-
tion rate that may be due to temporary decreased renal
blood ﬂow and sustained increases of SCr caused by
intrarenal insults (tubular or glomerular cell death as a
result of prolonged ischemia, sepsis, or nephrotoxins).
Consequently, the current deﬁnitions of AKI may
overestimate presumptive tubular cell injury in vol-
ume-depleted patients. In addition, patients with
decreased muscle mass may not demonstrate a robust
increase in SCr even with substantial renal injury. SCr
is a delayed and an insensitive marker of renal injury2
that does not accurately reﬂect the proportion of
injured nephrons.3 Indeed, recent work shows that
the level of SCr does not predict morbidity and mor-
tality as strongly as the duration of its elevation.4
Hence, it is critical to discover tools in addition to
AKIN and KDIGO deﬁnitions that distinguish tran-
sient from prolonged AKI.3
CLINICAL RESEARCH V Au et al.: NGAL and Sustained/Intrinsic AKI After SurgeryUsing the AKIN or KDIGO SCr criteria, the incidence
of postoperative AKI varies from around 1% after
general surgery to as high as 25% to 30% after cardiac
surgery.5,6 Preexisting risk factors include advanced
age, male gender, obesity (high body mass index), hy-
pertension, diabetes, chronic kidney disease, congestive
heart failure, ascites, and a high preoperative American
Society of Anesthesiology class. Emergent, i.p., or
high-risk surgery poses an increased risk of post-
operative AKI, which may be attributed to intra-
operative hypotension or shock, and nephrotoxic
insults such as i.v. contrast agents, aminoglycoside
antibiotics, or immunosuppressive drugs.5–7
It is no surprise, therefore, that postoperative AKI is
associated with increased intensive care unit and hos-
pital length of stay, cost, and mortality.8 Postoperative
AKI is a major risk factor for the development of
nonrenal complications and an independent contrib-
utor to mortality in non-cardiac surgery.9,10 Nonethe-
less, studies based on the AKIN or KDIGO deﬁnitions of
AKI may overestimate the effect of tubular damage
because SCr does not differentiate between brief and
prolonged duration of azotemia, or separate different
causes that increase SCr. Prerenal azotemia may prog-
ress to intrinsic acute kidney injury if not rapidly
treated, but the slow increase in SCr not only delays the
diagnosis of AKI, but also prevents timely intervention
of protective therapy at an early enough stage of injury
to potentially alter outcome. This has sparked an
ongoing search for early biomarkers of tubular injury
that is typiﬁed by prolonged azotemia.
Neutrophil gelatinase–associated lipocalin (NGAL) is
a small, 23-kDa protein that is an early biomarker for
ischemic, septic, or nephrotoxic kidney injury.11 It is
normally produced at low levels by the epithelial cells
of the kidney, but it is quickly upregulated in the thick
ascending limb of the loop of Henle and the collecting
ducts within 3 hours of tubular epithelial injury.3,10
Urinary and plasma NGAL increases rapidly and pro-
portionally to the severity and duration of the
insult.3,12–14 These responses were conserved in chil-
dren and adults, and across many different animal
models. Its potential usefulness as a clinical biomarker
is enhanced because NGAL is a protease-resistant
polypeptide detectable in plasma and urine through
automated clinical bioanalyzers, quantitative enzyme-
linked immunosorbent assay, or semiquantitative
immunoblot techniques.14
Urinary NGAL has been evaluated as an early
biomarker of renal tubular damage in acute clinical
settings such as the operating room, intensive care
unit, and emergency department, in high-risk pro-
cedures such as cardiac surgery and radiocontrast in-
jection, and after adult and pediatric kidney and liver4transplantation.2,3,10,13,15–18 There is considerable evi-
dence that compared to increases in SCr, NGAL better
detects early or subclinical kidney injury, and better
predicts dialysis requirement and mortality.3
There is also considerable evidence that elevated
urinary NGAL can distinguish true renal tubular
injury from hemodynamic variations and volume
depletion days before serial measurements of SCr make
these diagnoses. In an emergency department study on
over 600 patients and in a validation study of over 1650
patients, Nickolas et al. found that a single urinary
NGAL measurement on admission could clearly
discriminate between prolonged AKI, deﬁned as an
elevation of SCr $1.5 times baseline sustained for $3
days, and transient AKI, deﬁned as transient elevated
SCr that resolved within 3 days.3,19 Nearly identical
data were found in cirrhotic patients, patients in
intensive care units, and in animal models, namely that
NGAL levels did not rise outside of the normal range in
patients deemed prerenal or transiently azotemic.20–22
The patients in many of these studies, particularly
the emergency department studies, represented a very
heterogeneous group of conditions and pathways to
renal injury. Here, we designed an observational study
to test the hypothesis that urinary NGAL could simi-
larly distinguish sustained AKI from transient AKI in a
general surgical population immediately after general
surgery.MATERIALS AND METHODS
We screened all adult patients undergoing any type of
general surgical procedure at Columbia University
Medical Center who were admitted to the Post Anes-
thesia Care Unit (PACU) with an indwelling urinary
catheter between March and July 2013. Patients were
excluded from consideration if they were less than 18
years of age; had preexisting end-stage renal disease
(chronic kidney disease stage 5); had undergone ne-
phrectomy; or were either a donor or a recipient of
renal transplantation. The Institutional Review Board
(IRB) of Columbia University approved the study (IRB
#AAAL4657) contingent on written informed consent
for the collection of urine prior to testing of the samples
in this study.
Within 2 to 3 hours of admission to the PACU, 10 ml
urine was collected from the urinary catheter collecting
system and centrifuged at 2000g for 20 minutes, and
the supernatant was frozen at –80 C and retained for
batch analysis approximately 4 months later. We
measured urinary NGAL by commercially available
enzyme-linked immunosorbent assay kits (Antibody-
Shop, Gentofte, Denmark) at the Irving Institute
for Clinical and Translational Research of ColumbiaKidney International Reports (2016) 1, 3–9
Table 1. Patient demographics (N ¼ 510)
Patient characteristics
Age 60.7 (15.5)
Height (cm) 166.7 (12.6)
Weight (kg) 82.5 (24.5)
BMI 30.5 (20.8)
Female 303 (59.4%)
Surgical procedures
Major abdominal 113 (22.2%)
Minor abdominal 9 (1.8%)
V Au et al.: NGAL and Sustained/Intrinsic AKI After Surgery CLINICAL RESEARCHUniversity. The limit of NGAL detection with this
research assay is 0.5 to 4.0 ng/ml, and intra-assay
variation of the urine is 2.1% (range: 1.3%–4.0%).
Urinary sodium (UNa) and urinary creatinine (UCr)
were also measured at the Irving Institute. Serum
sodium (SNa), SCr, and blood urea nitrogen (BUN)
were determined by the clinical laboratory of
Columbia University Medical Center as dictated by
the clinical care for the patients. The fractional
excretion of sodium (FENa) was calculated by the
formula (SCr  UNa) / (SNa  UCr). Estimated creat-
inine clearance was derived using the method of
Cockcroft and Gault.23
We deﬁned postoperative AKI by the AKIN stage 1
SCr criterion as follows: an absolute increase in SCr $
0.3 mg/dl ($ 26.4 mmol/l) within 48 hours after sur-
gery. We deﬁned transient AKI as an increase of SCr
by $0.3 mg/dl ($26.4 mmol/l) within 48 hours that
decreased to less than 0.3 mg/dl ($26.4 mmol/l) by 72
hours after surgery. Sustained AKI was deﬁned as an
increase of SCr by$0.3 mg/dl ($26.4 mmol/l) within 48
hours that remained elevated at 72 hours and more
after surgery. These deﬁnitions of sustained and tran-
sient AKI have previously been used in a cohort of
patients admitted to the emergency department.19
Comparisons and correlations between groups were
made by an unpaired t-test or Pearson’s test for cor-
relation for values with Gaussian distribution and by
Mann–Whitney (Wilcoxon rank) test or Spearman’s for
correlation for continuous variables without normal
distribution. Gaussian distribution was determined
using the Kolmogorov–Smirnov test. Categorical data
were compared using the c2 or Fisher exact test. P
values were 2-tailed, and P < 0.05 was considered
signiﬁcant. Receiver operating characteristic (ROC)
curves were plotted, and the point on the ROC curve
closest to sensitivity ¼ speciﬁcity ¼ 1 was considered
the best cutoff value. Analysis of variance (ANOVA)
with Tukey’s range test was used to compare multiple
groups. We used PASW 18.0 (IBM Inc., Armonk, NY)
and GraphPad Prism 6.0 (San Diego, CA) software for
statistical analysis.Gynecological 46 (9.0%)
CNS neurosurgery 24 (4.7%)
Other neurosurgery 24 (4.7%)
Orthopedics 95 (18.6%)
Spine 48 (9.4%)
Thoracic 55 (10.8%)
Vascular major 19 (3.7%)
Vascular minor 5 (1.0%)
Angiogram 7 (1.4%)
Urology major 32 (6.3%)
Urology minor 19 (3.7%)
Other 14 (2.7%)
Data are reported as mean and SD or number and percentage, as appropriate.
BMI, body mass index; CNS, central nervous system.RESULTS
Patient Characteristics
We screened a total of 543 patients between March and
July 2013. Of these, 15 patients met exclusion criteria
(6 living-donor kidney transplantation; 6 cadaveric
kidney transplant recipients; 3 patients undergoing
nephrectomy), and 18 patients were excluded because
their records were incomplete. We analyzed data from
510 patients, whose mean age was 60.7  15.5 years,
and of whom 59.4% were female. The most commonKidney International Reports (2016) 1, 3–9procedure groups were major abdominal surgery,
including pancreatectomy, exploratory laparotomy,
colectomy, or gastric bypass surgery; and major or-
thopedic surgery, including total knee or total hip
replacement and open reduction and internal ﬁxation
of hip fractures (Table 1). Patients with AKI had a
baseline SCr of 1.46  1.39 mg/dl compared to a
baseline SCr of 1.09  3.79 mg/dl in patients without
AKI (not signiﬁcant).
Sustained, Transient, and No AKI by SCr Criteria
Seventeen patients had stage 1 AKI (3.3%) as deﬁned
by AKIN criteria (SCr increase$0.3 mg/dl [26.5 mmol/l]
or increase to 1.5-fold or more from baseline). These
patients had higher urinary NGAL levels than patients
without AKI: 122.9  305.7 ng/ml versus 31.9  113.0
ng/ml (P < 0.01). The area under the curve (AUC)
of the ROC curve of urinary NGAL to predict AKI
was 0.738 (95% conﬁdence interval [CI]: 0.616–0.860,
P < 0.005).
Nine of 510 patients (1.76%) met our criteria for
sustained AKI as follows: SCr elevated by $0.3 mg/dl
within 48 hours of surgery that persisted for $72
hours. Another 8 patients (1.6%) met our criteria for
transient AKI as follows: SCr elevated by $0.3 mg/dl
within 48 hours of surgery that normalized within 48
to 72 hours. The remaining 493 patients (96.7%) did
not meet SCr criteria for either transient or sustained
AKI (Figure 1).
We compared urinary NGAL levels in patients who
met SCr criteria for sustained AKI, transient AKI, or
normal renal function by ANOVA and Tukey’s post hoc5
Table 2. Urinary sodium, urinary creatinine, fractional excretion of
sodium, and urinary NGAL in patients with sustained and transient
acute kidney injury and normal postoperative serum creatinine
Sustained AKI
N [ 9
Transient AKI
N [ 8
No AKI
N [ 493 P value
Urinary sodium
(mmol/l)
60.9  34.8 75.5  41.7 114.6  54.7 P < 0.05
P values post hoc
test (Tukey)
0.84 0.11
0.01
Urinary creatinine
(mg/dl)
93.6  64.6 108.2  50.7 68.6  55.9 NS
FENa 2.07  3.74 1.45  1.57 2.66  12.27 NS
NGAL (ng/ml) 204.8  412.0 30.8  25.9 31.9  113.0 P < 0.0001
P values post hoc
test (Tukey)
0.01 1.0
0.0001
One-way analysis of variance and Tukey’s post hoc multiple comparison test to
compare mean values across the groups.
AKI, acute kidney injury; FENa, fractional excretion of sodium; NGAL, neutrophil
gelatinase–associated lipocalin; NS, not signiﬁcant.
Figure 1. Perioperative changes in SCr in patients with sustained
($3 days) or transient (<3 days) AKI or no AKI. Mean  SEM,
P < 0.05: *ANOVA comparison of groups, Tukey’s post hoc test;
#sustained versus no AKI; ^transient versus sustained AKI;
þtransient versus no AKI. AKI, acute kidney injury.
CLINICAL RESEARCH V Au et al.: NGAL and Sustained/Intrinsic AKI After Surgeryrange test. Mean immediate postoperative urinary
NGAL levels in patients who developed sustained AKI
were 204.8  411.9 ng/dl, and were signiﬁcantly
higher by ANOVA (P < 0.001) than in those who
developed transient AKI (30.8  36.5 ng/dl) or who had
normal renal function (31.9  113 ng/dl) (Figure 2).
Tukey’s post hoc test conﬁrmed that urinary NGAL
levels in patients with sustained AKI were signiﬁcantly
higher than those in patients with transient AKI or
those with normal renal function, and that there was no
signiﬁcant difference in urinary NGAL between the
latter 2 groups. The AUC of the ROC curve of urinary
NGAL to detect sustained AKI was 0.851 (95% CI:
0.773–0.929, P < 0.001). The best cutoff was 12.52 ng/
ml, with a sensitivity of 70.1% (95% CI: 65.8%–
74.0%), a speciﬁcity of 88.9% (95% CI: 51.8%–
99.7%), and a likelihood ratio of 6.305. In comparison,
the AUC of UNa to predict sustained AKI was 0.786
(95% CI: 0.673–0.900, P < 0.005) (Table 2).Figure 2. Urinary NGAL levels in patients with no AKI, transient AKI
(<3 days), or sustained AKI ($3 days) by AKIN criteria. P values
derived from ANOVA with Tukey’s post hoc tests. AKI, acute kidney
injury; NGAL, neutrophil gelatinase–associated lipocalin.
6Impact of AKI and Urinary NGAL on Post-
operative Outcome
Patients who developed sustained AKI had signiﬁ-
cantly longer hospital length of stay after surgery
(22.4  18.5) than patients who had transient AKI
(13.4  10.5 days) or normal renal function (4.3  5.0)
(P < 0.001, ANOVA with Tukey’s post hoc test).DISCUSSION
Our study demonstrates that in a large cohort of pa-
tients undergoing general surgery, immediate post-
operative urinary NGAL levels were signiﬁcantly more
elevated in patients who went on to have sustained ($3
days) elevations of SCr (sustained AKI) compared to
those with transient AKI or no elevations in SCr
(normal). Urinary NGAL was able to predict sustained
AKI with an AUC of the ROC curve of 0.851, indicating
that urinary NGAL levels correlated with severe renal
injury days before SCr increases and demonstrates a
sustained course. Urinary NGAL had greater discrimi-
natory power to detect sustained AKI immediately after
surgery than either UNa, FENa, or the BUN-to-SCr ra-
tio, supporting its potential usefulness in providing
prognostic information and guiding the nature and
timing of potential protective interventions. UNa is
seldom used to determine prerenal state, as it depends
on diuretics or the type of i.v. ﬂuids administered
perioperatively.
Patients in our study who developed transient SCr
elevations had urinary NGAL levels indistinguishable
from those of patients whose SCr remained normal.
Transient elevations of SCr most likely reﬂect a decrease
in glomerular ﬁltration rate caused by hypovolemia
rather than tubular or glomerular cell death. This is
frequently referred to as a prerenal syndrome orKidney International Reports (2016) 1, 3–9
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SCr >20, FENa <1%), in humans3 and in mice.22 Our
observations, which conﬁrm those of Nickolas et al.3,19
and other investigators,20,21,24 provide strong clinical
evidence that transient azotemia does not necessarily
cause tubular injury and the genetic expression of
urinary NGAL. Instead, transiently elevated SCr is a
consequence of renal hypoperfusion that is reversed
with volume restoration or hemodynamic stabilization
without obvious long-term SCr elevation. However,
using AKIN criteria these patients would be assigned
the same category as patients who have sustained,
intrinsic AKI. Therefore a substantial number of
patients who meet the RIFLE, AKIN, or KDIGO criteria
of “AKI” may not have tubular injury resulting in the
release of NGAL into the urine; that is, they may
have SCr elevation without true acute kidney tubular
injury. Moreover, it has recently been observed that
false-positive diagnosis of AKI is relatively common
with small changes in SCr because of its inherent vari-
ability when baseline values are elevated.25 Conversely,
the ability of NGAL to predict AKI in some studies may
have been impaired by including patients whose tran-
sient elevations of SCr may have met AKIN criteria
without actual tubular injury and NGAL expression.
As a consequence of the “overdiagnosis” of AKI by
RIFLE, AKIN, or KDIGO criteria, the incidence and
prevalence of mild to moderate kidney injury may be
overestimated in many current studies, and the adverse
impact of “true” AKI may be underestimated by dilu-
tion with the more benign syndrome of transient
azotemia that can be due to hemodynamic variation and
volume depletion (“prerenal azotemia”). This is further
emphasized by our observation that patients who had
substantial early elevation in urinary NGAL (AKI) went
on to have sustained ($3 days) elevation in SCr that
was associated with signiﬁcantly prolonged hospital
length of stay.
Although, as mentioned above, our observations
support those of Nickolas et al.,3,19 there are some very
important differences between the 2 studies. In the
emergency department study the Risk of the RIFLE
criteria was used, a much more stringent criterion for
AKI (increase of SCr by 1.5 times baseline) than stage 1
of the AKIN criteria (increase in SCr by 0.3 mg/dl from
baseline). The incidence of sustained AKI and transient
azotemia in our study was much lower (1.6% vs. 4.7%
and 1.76% vs. 13.8%, respectively). This is consistent
with a previous large population-based study that
found that the incidence of AKI was only 0.8% in
patients with previously normal renal function
undergoing non-cardiac surgery.7 Despite the low
incidence of sustained AKI and transient azotemia in
general surgical patients, urinary NGAL was clearlyKidney International Reports (2016) 1, 3–9able to distinguish between the 2 entities immediately
after surgery. This could be particularly useful if rapid
methods of measuring NGAL are used that provide
results within hours. Due to its longer processing time,
enzyme-linked immunosorbent assay to detect NGAL is
not feasible for clinical use.
We did not measure plasma NGAL, which has the
advantage of allowing its determination in the setting
of rapidly changing urine output. However, plasma
NGAL derives not only from the kidney but also from
other organs exposed to the same injury. Nonetheless,
meta-analysis suggests that plasma and urinary NGAL
measurements perform similarly well in the diagnosis
of AKI and both offer an advantage over SCr.13
NGAL has been studied in a range of clinical settings
in children and adults, but most studies have focused on
patients undergoing cardiac surgery or liver trans-
plantation or who are critically ill. Initial studies of
NGAL in pediatric patients demonstrated much higher
AUCs of the ROC curve of>0.9;3,16,26–28 but this has not
been sustained in some recent studies in adult patients—
for example, undergoing cardiac surgery; critically ill in
the ICU; and after contrast exposure in coronary angi-
ography.12,17,29–32 NGAL’s lower discriminatory power
in adults (0.85 for sustained AKI in this study) is likely
attributable most critically to variables such as the
prevalence of transient prerenal azotemia and preexist-
ing kidney disease and other comorbidities resulting in a
more heterogeneous study group10,33 and potentially
contributions from different NGAL molecular species,
which older assays failed to differentiate.
A limitation of our study is that the timing of uri-
nary sampling for NGAL in the PACU was rather
loosely deﬁned as within a few hours after admission.
In contrast, most studies on renal biomarkers sample at
speciﬁc time points after surgery or potential renal in-
sults so as to capture the optimal timing to utilize
NGAL.2,14,16,32 NGAL levels do change with time after
surgery,15 but most diagnostic tests of organ injury—
troponin being the most obvious example—are per-
formed at varying time points after the insult. In our
study we tried to replicate the potential clinical use of
measuring NGAL in the PACU, and a speciﬁc time point
for sampling is not practical in normal clinical practice.
Our study was designed to most realistically simulate
diagnostic testing in a typical clinical setting while
sampling fell within the window of peak performance of
urinary NGAL (3–12 hours after renal injury).
A further limitation of our study is the low rate of
events. This incidence of AKI that we observed is
similar to previously reported frequency of AKI in pa-
tients undergoing general, non-cardiac surgery.5 Even
with this low event rate our results are robust and
comparable to those of the study of NGAL in patients7
CLINICAL RESEARCH V Au et al.: NGAL and Sustained/Intrinsic AKI After Surgeryadmitted to the emergency department.19 Studying
higher-risk patients will likely increase the incidence of
AKI and therefore the statistical power, but results of
such studies may be less generalizable.
In conclusion, we have demonstrated that in patients
undergoing general surgery, the incidence of SCr
elevation is low, less than 4%. Nonetheless, post-
operative urinary NGAL concentrations predicted the
subsequent development of sustained AKI in a subset
of those patients. Our study conﬁrms the observations
of Nickolas et al.3,19 and other investigators20,21,24 that
transient elevations in SCr seen with prerenal azotemia
are not associated with NGAL expression outside of the
normal range, and therefore likely do not represent
tubular injury. Urinary NGAL measurements may
therefore facilitate the rapid diagnosis of true intrinsic
AKI and distinguish it from transient SCr elevation due
to hemodynamic variations and volume depletion pre-
viously called prerenal azotemia.
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